DOCK7 and colorectal carcinoma: We subsequently found that EVs derived from DOCK7‐overexpressing RAW264.7cells (oeDOCK7‐EVs) facilitated the metastatic ability of CRC cells via Transwell assays, which were alleviated when the cells were cotreated with NSC23766 (Figure 5G).